Genmab — September 2015
-
Enig Solsen
-
-
Han er da noget defensiv novod
-
ABG Sundal har regnet på at den gennemsnitlige hastighed for BTD produkter er 157 dage hvilket vil betyde Dara approval 13/12 2015
-
Men Blincyto brugte kun 75 dage hvilket så ville give Dara approval ultimo september
-
Alt kan ske
-
Rolling cutter vel også tiden?
-
ja burde den
-
men alle BTD lægemidler anvender stort set rolling, så er med i betragtningen ovenfor
-
Ok.
-
-
Anonyme kører det løb som altid.
-
Du er ikke ked af det Hr. larsen: http://play.borsen.dk/news
-
genmab skal i 1000
-
Det sagde jeg IKKE..Genmab stiger op mod kurs 1000 ved godkendelse.
-
Jeg bestemmer ikke selv overskrifterne.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind